New research into a chemical produced by a caterpillar fungus that has shown promise as a possible cancer treatment has revealed how it interacts with genes to interrupt cell growth signals. The ...

Paris, France, 6th November 2024 – PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, has ...

The NHS Business Services Authority (NHSBSA) has released the latest report on Prescribing Costs in Hospitals and the Community for England in 2023/24. The report provides a national view of ...

Scottish scientists have developed a low-cost, flexible device that can help prevent blood clots for patients after an operation. Their polymer-based sensor fits underneath bandages and compression ...

Study will investigate the benefits of combining Lisata's novel product candidate, certepetide, with ValoTx's platform technology, PeptiCRAd, and a checkpoint inhibitor in preclinical tumor models ...

Bristol Myers Squibb today announced the appointment of Karen Costello as the new General Manager for its commercial operations in Ireland. In this new role, Karen will lead the delivery of Bristol ...

The third quarter of 2024 presented Genmab with additional opportunities to progress towards our goal of fundamentally transforming the lives of people with cancer and other serious diseases. The ...

Quarter Results/9 Month figuresRHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed   07.11.2024 / 08:59 CET/CESTThe issuer is solely responsible for the content ...

Enteralia Bioscience SRL Acquires TFarma to Strengthen Presence in Italy's Nutraceutical and Medical Device MarketMILAN, ITALY / ACCESSWIRE / November 7, 2024 / Enteralia Bioscience SRL ("Enteralia") ...

Reaccreditation Highlights OptiMed's Continued Commitment to Excellence in Patient Care and Quality StandardsKALAMAZOO, MI / ...

Striking new figures from the Office for National Statistics (ONS) reveals millennials (people born between around 1981-1996) ...

The global microfluidics market is on track for exceptional expansion, with projections showing a rise from USD 7,711.9 million in 2023 to an extraordinary USD 23,739.1 million by 2033, representing a ...